Core Viewpoint - Anuo Youda Gene Technology (Beijing) Co., Ltd. has submitted an IPO application to the Hong Kong Stock Exchange, backed by notable investors including Xia Zuoquan, a co-founder of BYD [2][4]. Company Overview - Anuo Youda focuses on molecular diagnostics, particularly in the IVD (in vitro diagnostics) medical device sector and multi-omics life science research services [3]. - The company was founded in April 2012 with initial funding from Xia Zuoquan, who provided several million yuan and holds 93.75% of the company's shares [4]. Investment Background - Xia Zuoquan is known for his early investment in BYD, which yielded over 10,000 times returns, and he currently holds 2.84% of BYD shares valued at over 30 billion yuan [4]. - Since its inception, Anuo Youda has raised a total of 1.539 billion yuan through six funding rounds, with investors including China Life, Northern Light Venture Capital, Guotai Junan, Ping An Group, and Gao Tejia Investment [5]. Shareholder Structure - As of the latest equity change in October 2022, Anuo Youda's valuation is approximately 4.05 billion yuan [6]. - Before the IPO, Xia Zuoquan directly held 9.95% of Anuo Youda's shares, valued at about 398 million yuan, with a return rate exceeding 40 times [7]. Recent Share Transactions - Early investors have begun to cash out as Anuo Youda's valuation increases, with notable transactions including Northern Light selling shares for 100 million yuan in 2017 and 171 million yuan in 2020 [9].

一周IPO动态，覆盖港股、美股、A股。 本文为IPO早知道原创 据 IPO早知道消息，矽电半导体设备(深圳)股份有限公司（以下简称"矽电股份"）于2025年3月24 日正式以"301629"为股票代码在深交所创业板挂牌上市。 成立于 2003年的矽电股份专注于半导体探针测试技术领域，主要产品为探针台设备，是中国大陆规 模最大的探针台设备制造企业。同时，作为中国最早研发探针测试技术的企业之一，矽电股份也是中 国大陆首家实现产业化应用的12英寸晶圆探针台设备厂商，已在多个半导体产品领域打破海外厂商 垄断。 这里不妨补充一点，探针测试技术主要应用于半导体制造晶圆检测 (CP, Circuit Probing)环节，也 应用于全流程晶圆接受测试(WAT 测试, Wafer Acceptance Test)、设计验证和成品测试(FT, Final Test)环节，是检测芯片性能与缺陷，保证芯片测试准确性，提高芯片测试效率的关键技术。 目前，矽电股份自主研发了多种类型应用探针测试技术的半导体设备，产品已广泛应用于集成电路、 光电芯片、分立器件、第三代化合物半导体等半导体产品制造领域，其探针测试系列产品已应用于士 兰微、比 ...